Cello Therapeutics, Inc.
Records under this name other than patents Cello Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Cello Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,353,466 | Methods and compositions for quantifying hemoglobin Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,415,338 | Oxygen Linked Pyrimidine Derivatives Term ended Term ended Nov 15, 2026 · High confidence | Term ended | Term ended Nov 15, 2026 | High confidence |
| US 8,318,503 | Method for determining the amount of conjugated taxane in polyglut acid-taxane conjugates Lapsed on the fee record Ended Nov 27, 2024 · USPTO record | Lapsed on the fee record | Ended Nov 27, 2024 | USPTO record |
| US 8,129,348 | Conjugates of Biologically Active Proteins Having a Modified in Vivo Half-Life Lapsed on the fee record Ended Mar 6, 2024 · Medium confidence | Lapsed on the fee record | Ended Mar 6, 2024 | Medium confidence |
| US 8,426,625 | Bis-platinum complexes with antitumor activity Formerly held Lapsed on the fee record Ended Apr 23, 2021 · USPTO record | Lapsed on the fee record | Ended Apr 23, 2021 | USPTO record |
| US 8,329,853 | Process for the preparation of poly-α-glutamic acid and derivatives thereof Lapsed on the fee record Ended Dec 11, 2020 · USPTO record | Lapsed on the fee record | Ended Dec 11, 2020 | USPTO record |
| US 6,586,429 | Tricyclic fused xanthine compounds and their uses Term ended Term ended Nov 29, 2020 · USPTO record | Term ended | Term ended Nov 29, 2020 | USPTO record |
| US 7,399,860 | Manufacture of polyglutamate-therapeutic agent conjugates Lapsed on the fee record Ended Jul 15, 2020 · USPTO record | Lapsed on the fee record | Ended Jul 15, 2020 | USPTO record |
| US 6,316,458 | Method of enhancing insulin action Term ended Term ended Apr 25, 2020 · USPTO record | Term ended | Term ended Apr 25, 2020 | USPTO record |
| US 7,173,041 | Polyglutamic acid-camptothecin conjugates and methods of preparation Lapsed on the fee record Ended Feb 6, 2019 · USPTO record | Lapsed on the fee record | Ended Feb 6, 2019 | USPTO record |